By using our website, you agree to the use of cookies as described in our Cookie Policy.

Close
Consilium-white-out.png Consilium Final logo.png Menu
Close
Twitter
  • About Us
    • Healthcare
    • Our values
  • Our expertise
    • Overview
      • Overview
    • Our experience
    • Case studies
      • Alliance for Regenerative Medicine
      • Sensyne Health
      • Cancer Research UK
      • Cambridge Innovation Capital
      • Vectura
      • CMR Surgical
      • Horizon Discovery
      • Immunocore
      • Quanta
  • Our team
  • News & insights
    • Consilium news
    • Consilium Conscience
    • Monthly intel
    • Events calendar
    • Email Alerts
  • Careers
  • Contact us

Consilium Conscience

  • Home/
  • News & insights/
  • Consilium Conscience/
  • From pre-IPO to sale: How Consilium works with listed companies –...

News & insights

  • Consilium news
  • Consilium Conscience
  • Monthly intel
  • Events calendar
  • Email Alerts
Tweets by ConsiliumHC

14th January 2021

From pre-IPO to sale: How Consilium works with listed companies – Horizon Discovery

 

Horizon Discovery was recently acquired by PerkinElmer for $383 million. To find out more about about how Consilium supported the transaction and the work we did with the Horizon since 2014, please watch this video.

 


Back to previous page
Twitter
Register for news and updates Line
  • Twitter
  • LinkedIn
  • Email

©2021 Consilium Strategic Communications

  • Accessibility
  • Privacy and cookie policy
  • Sitemap

emperor.works